The ethical choice
For immediate release

Study Proves Alpha-Stim Helps Pain & Anxiety in Advanced Cancer Patients

A recent clinical research study has proved the effectiveness of the Alpha-Stim cranial electrotherapy stimulation (CES) device for cancer patients, effectively treating their resultant pain, anxiety, insomnia and depression.

The study was conducted by the MD Anderson Cancer Center, one of the largest and most prominent cancer research centres in the world and was pre-released by the Journal of Pain and Symptom Management. The findings revealed that advanced cancer patients who were treated with cranial electrotherapy stimulation (CES) via the handheld, non-invasive medical device called Alpha-Stim for just four weeks, saw a significant improvement of pain, anxiety, depression and sleep.

The Alpha-Stim is now being used by the NHS to help treat anxiety having been the subject of a major NHS study into anxiety in the UK [2]. It has more clinical research than any other device in its class but there hadn’t been any published studies in patients with advanced cancer until this one. The study examined the safety and efficacy of this non-drug treatment option, affirming years of research that Alpha-Stim is extremely effective, with no serious adverse effects and no risk of addiction.

Daniel L. Kirsch, PhD, inventor of the Alpha-Stim and Chairman of Electromedical Products International, Inc., noted that one of the most powerful things about the current study is that it asserts the power of Alpha-Stim to go beyond typical prescription medications. “I am very happy to see that Alpha-Stim technology has been able to help advanced cancer patients on multiple issues during the most difficult period in their lives, with a study that proves it,” Kirsch said.

The study concluded that ‘the use of CES was associated with significant improvement of depression, anxiety, pain, and sleep scores’ and proves that Alpha-Stim is a viable treatment option for one of the most difficult to treat conditions.

The Alpha-Stim AID works by sending a signal to the brain that is refined and filtered, providing a very clear message for the mind to respond to. This specific form of current possesses elements that are totally unique to AS. It uses a specific wave form with a 10 second pulse width. During 10 seconds of exposure to the AS, an imperceptible microcurrent passes across the brain via ear-clips coated with a conducting fluid. The current contains a wide range of frequencies – which can be thought of as playing all the keys on the piano at once. The more frequencies that are transmitted to the brain, the more likely it will find a frequency that it responds to. It constantly changes the frequency based on the information it receives from the brain thus ensuring an optimum result during every session.

The device works on the same electrical pathways that naturally occur in the brain and stimulates the nerve cells in the brain stem the control centre of the brain. 98 percent of the communication in the brain is electrical rather than chemical and the treatment encourages the production of alpha-waves in the brain. It also stimulates the brain cells to trigger a reaction to produce Serotonin. Anti-depressant drugs (SSRI’s) do the same, but cranial electrotherapy stimulation does this without side-effects. Its positive effects are also cumulative, suggesting that the Alpha-Stim may bring about a permanent positive change in our neurological make-up.

The Alpha-Stim AID retails for £549 or is available on a buy-to-rent scheme from £51 a month. For more information please visit or call 01487 208041.


[1] Sriram Yennurajalingam, Duck-Hee Kang, Wen-Jen Hwu, Nikhil S. Padhye, Charles Masino, Seyedeh S. Dibaj, Diane D. Liu, Janet L. Williams, Zhanni Lu, Eduardo Bruera, “Cranial Electrotherapy Stimulation for the Management of Depression, Anxiety, Sleep Disturbance, and Pain in Patients with Advanced Cancer: A preliminary study”, 27/8/2017
[2] Professor Richard Morriss, University of Nottingham, ‘Clinical and cost effectiveness of Alpha-Stim AID Cranial Electrotherapy Stimulations (CES); a naturalistic study in patients with a primary working diagnosis of moderate-to-severe generalised anxiety disorder who did not improve with low intensity psychological therapy intervention’, September 2016.


Richard Morriss, Professor of Psychiatry at Nottingham University
Professor Richard Morriss is a Consultant in General Adult and Community Psychiatry with Nottinghamshire Healthcare NHS Trust and Professor of Psychiatry and Community Mental Health at the University of Nottingham. He trained in psychiatry in Leeds, Johns Hopkins Hospital in Baltimore United States, Oxford and Manchester. He has a MD from University of Leeds.
Professor Morriss has clinical interests in mood disorders, somatization and primary care psychiatry. His research interests are in the management of bipolar affective disorder, depression and medically unexplained symptoms in primary and secondary care settings.
He was also a member of the NICE Guideline Development Group (GDG) for Bipolar Disorder and is currently a member of the NICE mental health panel.

Dr. Lesley Parkinson – Consultant, Clinical-Psychologist, Specialist in Neuropsycho-Physiology
Possibly the UK’s most experienced consultant clinical-psychologist in BioFeedback, Neurofeedback, Hemoencephalography and quantitative electro-encephalographic assessment (qEEG) and brain health


PR Newsroom - The Microcurrent Site: Alpha-Stim
Further information
For more information about Alpha-Stim AID, case studies or product and lifestyle images, please contact:
Ian & Jenny Liddle, Excellart, 01450 219 246,,

Back to Alpha-Stim
Next Release
About Us
Marketing & Design
PR Newsroom
Public Relations
Training & Advice
Contact Us
PR Newsroom
West Midlands Vegan Festival
Max Wiseberg (airborne allergies)
Howard Carter (bite prevention)
Daniel Brash (pharmacist)
Julie Silver (nutritional therapist)
Martin Fodor (green & eco issues)
Natural Health & Beauty:
Cisca Saltpipe

Julie Silver
+44 (0) 1450 219246